Episode Summary
Executive Summary: Four women health experts argue that women’s health has been underfunded, understudied, and dismissed, leading to delayed diagnoses and poor outcomes across menstrual health, PCOS, endometriosis, fertility, contraception, and menopause. They stress that cycles are a vital health signal, hormones are dynamic body-wide messengers, and lifestyle plus targeted medical therapy can improve outcomes and long-term health.
Main Topics: Why women’s health needs distinct attention (Priority: 5/5): The panel explains that women are the majority of the population yet remain underrepresented in research, clinical education, and funding, creating systematic gaps in care. Menstrual cycle as a marker of whole-body health (Priority: 5/5): Irregular, absent, heavy, or painful periods are presented as red flags for hormonal, metabolic, inflammatory, or structural problems—not just reproductive issues. PCOS, insulin resistance, and lifestyle intervention (Priority: 5/5): PCOS is framed as a metabolic-hormonal condition strongly linked to insulin resistance and inflammation, with food, sleep, stress reduction, and resistance training as key management tools. Endometriosis, pain dismissal, and infertility (Priority: 5/5): The discussion highlights the long diagnostic delay, severe pain burden, fertility implications, and limited treatment options for endometriosis, including surgery and symptom control. Contraception tradeoffs and hormone suppression (Priority: 4/5): The panel weighs pill, IUD, implant, ring, and natural family planning, emphasizing that contraceptives can affect ovulation, estrogen production, mood, libido, and bone health. Perimenopause and menopause as major health transitions (Priority: 5/5): Perimenopause is described as a years-long hormonal transition that can affect mood, cognition, sleep, libido, bones, and cardiovascular health long before periods stop. Fertility planning, egg quality, and egg freezing (Priority: 4/5): The experts urge earlier fertility awareness, explaining egg count decline, age-related egg quality loss, and the value and limits of egg freezing and IVF.
Key Arguments: Women’s health is not a niche issue; women are 51% of the population and make most healthcare decisions, yet receive less than 1% of some research funding over age 40. Menstrual irregularity, absent periods, heavy bleeding, and severe pain should be treated as clinical warning signs, not normalized or dismissed. PCOS is driven largely by insulin resistance and inflammation; many symptoms can improve with plant-forward nutrition, better sleep, stress reduction, and muscle-building exercise. Endometriosis is a chronic inflammatory disease that often takes 7–10 years to diagnose and can severely damage fertility and quality of life. Birth control can be useful, but it is not neutral: some methods suppress ovulation and may lower estrogen, affecting mood, libido, and bone-building years. Perimenopause begins before the final period and can produce major symptoms even when cycles still look regular; many women should be assessed and possibly treated earlier. Egg count and egg quality decline with age, making fertility more time-sensitive than many women realize; fertility planning should start earlier if parenthood is a goal. Lifestyle factors matter for fertility and hormonal health in both women and men, including sleep, stress, body composition, inflammation, heat exposure, smoking, alcohol, and cannabis use.
Data Points: Women in population: 51% - Used to argue women are the majority, not a minority, in healthcare needs. Research spending on women over 40: <1% - Claimed share of the $450 billion U.S. research spend directed to women over 40. Women’s share of healthcare decisions: 80% - Women make most healthcare decisions for themselves and others. Longevity gap: ~6 years longer - Women live about six years longer than men on average. Life spent in poor health vs men: 20% more of life - Women spend more of their longer lifespan in chronic disease or mental health disorder states. Unexplained infertility linked to endometriosis: 50% - Half of patients with unexplained infertility may have endometriosis. Endometriosis diagnosis delay: 7–10 years - Average time from symptom onset to diagnosis. Women required in studies: 1993 - Women were not required to be represented in studies until 1993. Average menstrual cycle range: 25–35 days - Suggested interval for a predictable cycle for many women. Gestational diabetes later type 2 risk: up to 50% within 10–15 years - Women who develop diabetes in pregnancy may later develop type 2 diabetes. Infertility and heart attack risk: 80% higher - Statistical association mentioned for infertility as a long-term risk marker. Infertility and metabolic syndrome risk: 75% higher - Risk increase discussed as part of later-life health consequences. PCOS prevalence among women with irregular cycles: ~10% or more - PCOS described as one of the leading causes of irregular menstrual cycles. Ferritin optimal level in clinic: 60–100 - Mentioned as an optimal range for performance-oriented care, above common lab cutoffs. Anemia prevalence in women 15–49 worldwide: ~30% - WHO estimate cited during iron deficiency discussion. Anemia prevalence in some regions: up to 50% - Reported for parts of South Asia and sub-Saharan Africa. Pregnancy loss frequency: 1 in 4 pregnancies - Used to normalize discussion of pregnancy loss and reduce stigma. Egg freezing uptake with coverage: up to 50% - In companies offering coverage, uptake rose dramatically compared with under 5% without it. Fecundability at age 30: ~20% per month - Monthly chance of conception with regular unprotected intercourse. Fecundability at age 35: 10–12% per month - Noted decline in monthly conception odds. Fecundability at age 38: 5% per month - Shows steep decline in fertility with age. Fecundability at age 40: 3% per month - Illustrates why family planning becomes more time-sensitive. Sperm lifespan in female reproductive tract: 5 days - Used to explain fertile window timing. Egg lifespan after ovulation: 24 hours - Used to define the narrow fertile window. Women with PCOS and insulin resistance: ~80% - Highlighted as the majority of PCOS patients. Mental health changes during perimenopause: ~40% increase - Cited as the rise in mental health issues across the transition. SSRI prescriptions across menopause transition: double - Used to show rising treatment of mood symptoms during menopause. Eligible women using menopause hormone therapy: ~4% - FDA-approved prescription uptake among eligible women in the U.S.
Pivotal Quotes: "Your body’s meant to work like clockwork." — Speaker in opening discussion: Introduced as a core framing for why irregular cycles matter medically. "Women are not little men." — Dr. Stacy Sims reference in discussion: Used to explain why female physiology requires separate research and treatment models. "We need to have these discussions publicly that we are seeing." — Natalie: On the lack of public education around hormones, menstrual health, and menopause.
Implications: Listeners are urged to track cycles, treat symptoms as data, and advocate for earlier evaluation. The field needs better sex-specific research, education, and individualized care, especially around hormones, fertility, and menopause.
About The Diary Of A CEO with Steven Bartlett
Steven Bartlett is a British entrepreneur, investor, and author. He’s the founder of Flight Story – a media company – and Flight Fund, an investment fund backing the next generation of category-defining businesses. He created The Diary Of A CEO to share the unfiltered pages of the personal diaries of the world’s most fascinating CEOs, experts, therapists, and leaders – with the hope that their lessons will help both you and him live better lives. DOAC is a double acronym: Diary Of A CEO, but also Dreamers, Open-minded, Awareness, and Connection.This is your corner of the internet to dream boldly, think openly, expand your awareness, and feel more connected. My New Book: https://g2ul0.app.link/DOAC IG: https://www.instagram.com/steven LI: https://www.linkedin.com/in/stevenbartlett-123
View all episodes from The Diary Of A CEO with Steven Bartlett